Literature DB >> 14535451

Diagnostic and prognostic value of serum lactate dehydrogenase (LDH) and LDH isoenzymes in canine lymphoma.

R Zanatta1, O Abate, A D'Angelo, B Miniscalco, A Mannelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14535451     DOI： 10.1023/b:verc.0000014201.82393.67

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN： 0165-7380            Impact factor:   2.459


× No keyword cloud information.
  5 in total

1.  Profiles and prognostic values of LDH isoenzymes in patients with non-Hodgkin's lymphoma.

Authors:  C Dumontet; J Drai; J Bienvenu; E N Berard; C Thieblemont; F Bouafia; F Bayle; I Moullet; G Salles; B Coiffier
Journal:  Leukemia       Date:  1999-05       Impact factor: 11.528

2.  Elevation of serum lactic dehydrogenase levels as an early marker of occult malignant lymphoma.

Authors:  Z Rotenberg; I Weinberger; Y Fuchs; A Erdberg; E Davidson; J Agmon
Journal:  Cancer       Date:  1984-10-01       Impact factor: 6.860

3.  Lymphomas in dogs. A morphologic, immunologic, and clinical study.

Authors:  P G Greenlee; D A Filippa; F W Quimby; A K Patnaik; S E Calvano; R E Matus; M Kimmel; A I Hurvitz; P H Lieberman
Journal:  Cancer       Date:  1990-08-01       Impact factor: 6.860

4.  Chronic lymphocytic leukemia in the dog: 22 cases (1974-1984).

Authors:  C E Leifer; R E Matus
Journal:  J Am Vet Med Assoc       Date:  1986-07-15       Impact factor: 1.936

5.  Prognostic significance of serum lactate dehydrogenase in malignant lymphoma.

Authors:  R J Schneider; K Seibert; S Passe; C Little; T Gee; B J Lee; V Miké; C W Young
Journal:  Cancer       Date:  1980-07-01       Impact factor: 6.860
  5 in total
  8 in total

1.  Clinical and immunophenotypic findings in 4 forms of equine lymphoma.

Authors:  Arianna Miglio; Chiara Morelli; Rodolfo Gialletti; Eleonora Lauteri; Monica Sforna; Maria Luisa Marenzoni; Maria Teresa Antognoni
Journal:  Can Vet J       Date:  2019-01       Impact factor: 1.008

2.  Association of Systemic Inflammatory and Immune Indices With Survival in Canine Patients With Oral Melanoma, Treated With Experimental Immunotherapy Alone or Experimental Immunotherapy Plus Metronomic Chemotherapy.

Authors:  Jéssica Soares Garcia; Victor Nowosh; Rossana Verónica Mendoza López; Cristina de Oliveira Massoco
Journal:  Front Vet Sci       Date:  2022-07-06

Review 3.  Clinical and Diagnostic Significance of Lactate Dehydrogenase and Its Isoenzymes in Animals.

Authors:  Robert Klein; Oskar Nagy; Csilla Tóthová; Frederika Chovanová
Journal:  Vet Med Int       Date:  2020-06-15

4.  Evaluation of serum thymidine kinase 1 activity as a biomarker for treatment effectiveness and prediction of relapse in dogs with non-Hodgkin lymphoma.

Authors:  Pierre Boyé; Franck Floch; François Serres; Kévyn Geeraert; Pierre Clerson; Xavier Siomboing; Mattias Bergqvist; Gabriel Sack; Dominique Tierny
Journal:  J Vet Intern Med       Date:  2019-05-25       Impact factor: 3.333

5.  Simultaneous evaluation of diagnostic marker utility for enzootic bovine leukosis.

Authors:  Misako Konishi; Sota Kobayashi; Taeko Tokunaga; Yuzumi Chiba; Toshiyuki Tsutsui; Shozo Arai; Ken-Ichiro Kameyama; Takehisa Yamamoto
Journal:  BMC Vet Res       Date:  2019-11-09       Impact factor: 2.741

6.  Hematological and biochemical profiles of canine CD45- T lymphomas are different from other immunophenotypes.

Authors:  Rosina Sánchez-Solé; Florencia Mosquillo; Paulo Jark; Martín Breijo; Paula Pessina
Journal:  Open Vet J       Date:  2021-12-21

7.  Pilot Study: Assessing the Expression of Serum Lactate Dehydrogenase and Peripheral Leukocyte Ratios in Canine Oral Malignant Melanoma.

Authors:  Ben Murray; Kelly L Bowlt Blacklock
Journal:  Vet Sci       Date:  2022-08-09

8.  A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management.

Authors:  Kiran Kumar Jagarlamudi; Laura Moreau; Sara Westberg; Henrik Rönnberg; Staffan Eriksson
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.